---
schema_version: "secwatch.filing_event.v1"
accession: "0001903596-24-000592"
form_type: "8-K"
ticker: "LUDG"
cik: "0001960262"
company_name: "LUDWIG ENTERPRISES, INC."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:23:50.285379+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ludwig Enterprises acquires mRNA Neuro Panel patent, serotonin assay IP from Nova Mentis

## Summary
- Acquired U.S. Patent Application 18/705375 and related IP for mRNA neuro panel and serotonin assay from Nova Mentis.
- Issued 750,000 shares of common stock to Nova Mentis, subject to one-year lock-up and quarterly sale limits.
- Company will pay a 5% royalty on commercialization: 2.5% each to Nova and Hausman until Hausman recovers $245,712 in unpaid consulting.
- IP includes data from ASD/Fragile X observational study and serotonin assays from UCF lab of Dr. Kiminobu Sugaya.
- Dr. Marvin Hausman, CSO, says IP represents over 10 years of mRNA research; intends to expand beyond breast cancer screening.

## SEC filing metadata
- accession: 0001903596-24-000592
- form_type: 8-K
- ticker: LUDG
- cik: 0001960262
- company_name: LUDWIG ENTERPRISES, INC.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1960262/000190359624000592/0001903596-24-000592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1960262/000190359624000592/ludg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001903596-24-000592
- JSON: https://secwatch.observer/filing/0001903596-24-000592.json
- Plain text: https://secwatch.observer/filing/0001903596-24-000592.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.